Ankylosing spondylitis

3 trials 2 recruiting MedDRA PT
3 Registered trials
2 Recruiting
3 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase III: 1 Phase II: 1 Phase IV: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial
  • AbbVie Deutschland GmbH & Co. KG Academic
    ABT-494
    2022-501018-78-00 9 countries 2020 n=272
    Ended

Phase II

1 trial
  • Merck Sharp & Dohme LLC Commercial
    TULISOKIBART
    2025-521059-21-00 3 countries 2025 n=62
    Recruiting

Phase IV

1 trial
  • Novartis Pharma AG Commercial
    IMP not specified
    2023-504417-67-00 7 countries 2020 n=323
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Merck Sharp & Dohme LLC Commercial 1 Phase II 1
Novartis Pharma AG Commercial 1 Phase IV 1
AbbVie Deutschland GmbH & Co. KG Academic 1 Phase III 0
New trials by year
2020
2
2025
1
← All indication landscapes